BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3708040)

  • 21. Phenelzine treatment of depression with chronic diarrhea.
    Weiss KJ; Schwartz HJ; Berrettini WH
    J Clin Psychiatry; 1982 Jun; 43(6):250-1. PubMed ID: 7085581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatographic determination of inhibition of monoamine oxidase activity in platelet rich plasma of depressed patients treated with phenelzine.
    Gupta RN; Steiner M
    Clin Chim Acta; 1985 Oct; 152(1-2):63-9. PubMed ID: 4053406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
    Ravaris CL; Robinson DS; Ives JO; Nies A; Bartlett D
    Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrelationship of hysteroid dysphoria and borderline personality disorder.
    Liebowitz MR; Klein DF
    Psychiatr Clin North Am; 1981 Apr; 4(1):67-87. PubMed ID: 7232238
    [No Abstract]   [Full Text] [Related]  

  • 27. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
    Joffe RT
    J Clin Psychiatry; 1988 Oct; 49(10):409-10. PubMed ID: 3170493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced catatonia.
    Herrmann N; Lieff SJ
    Can J Psychiatry; 1988 Oct; 33(7):633-4. PubMed ID: 3197020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Harrison W; Quitkin FM
    Psychopharmacol Bull; 1987; 23(1):169-72. PubMed ID: 3602314
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenelzine-associated inappropriate ADH secretion.
    Giese AA; Leibenleft E; Green S; Moricle LA
    J Clin Psychopharmacol; 1989 Aug; 9(4):309-10. PubMed ID: 2768546
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early and late side effects of phenelzine.
    Evans DL; Davidson J; Raft D
    J Clin Psychopharmacol; 1982 Jun; 2(3):208-10. PubMed ID: 7096609
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
    Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
    Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 36. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 37. Bradycardia induced by an interaction between phenelzine and beta blockers.
    Reggev A; Vollhardt BR
    Psychosomatics; 1989; 30(1):106-8. PubMed ID: 2913594
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phenelzine and acetylator phenotype.
    Rowan PR; Paykel ES; West PS; Rao BM; Taylor CN
    Neuropharmacology; 1981 Dec; 20(12B):1353-4. PubMed ID: 7322308
    [No Abstract]   [Full Text] [Related]  

  • 40. First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients.
    Georgotas A; Reisberg B; Ferris S
    Arch Gerontol Geriatr; 1983 Nov; 2(3):249-54. PubMed ID: 6651397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.